Sigma-2 receptor ligands have shown efficacy in various tumour cells using cell culture and animal models (Ostenfeld et al, 2005; Kashiwagi et al, 2007, 2009) by multiple signalling pathways. The gene discussed is TMEM97; the disease is neoplasm.